Benjamin Qiu
Partner @ Advantech Capital
Beijing, China
Benjamin Qiu is a Series A investor at Advantech Capital in Beijing focused on Health Care and Pharmaceutical. Benjamin Qiu - Partner @ Advantech Capital
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Benjamin Qiu invests in
Stages Benjamin Qiu invests in
Countries Benjamin Qiu invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 4 (67%)
- Pharmaceutical 4 (67%)
- Biotechnology 3 (50%)
- Therapeutics 2 (33%)
- Medical 1 (17%)
Stage
- Series A 4 (67%)
- Series B 2 (33%)
Country
- China 3 (50%)
- United States 2 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Innoforce Pharmaceuticals
|
Innoforce is a biopharma manufacturing firm that facilitates the development and commercialization of innovative medicines. | $58.8M / Series A / Dec 06, 2021 | |
Ablaze Pharmaceuticals
|
Ablaze Pharma is a clinical stage bio-pharmaceutical company that is focused on developing Targeted Radiotherapy (TRT) to benefit cancer patients. | $75M / Series A / Nov 29, 2021 | |
Onconano Medicine
|
OncoNano Medicine is a biotech company that develops nanotechnology-enabled fluorescent probes to help cancer surgeons visualize tumors during surgery, allowing them to excise tumors more precisely. The fluorescent sensor targets the different pH signals, thus making them glow so they are easier to distinguish from normal tissue.OncoNano Medicineis a UTSW spinoff company based in Dallas, Texas. | $50M / Series B / Jun 17, 2021 | |
Alphamab Oncology
|
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipelinein oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally. | $60M / Series B / May 28, 2019 | |
|
Alphamab Oncology
|
Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipelinein oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally. | $100M / Series A / Nov 16, 2018 | |
KBP Biosciences
|
KBP is a world-class biotechnology research & development organization dedicated to providing innovative therapies for unmet medical needs. | $76M / Series A / Jan 05, 2018 |
Co-Investors
China Venture Capital
2 deals together
PAG
2 deals together
Bay City Capital
1 deal together
CASH Capital
1 deal together
China Highrun Capital Limited
1 deal together
CICC
1 deal together
About Advantech Capital
Advantech Capital is a private equity fund, focused on innovation-driven growth capital in China.
Advantech Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Hebert Kee Chan Pang
Director
|
|||
Jennifer Jin
Partner
|
|||
|
Benjamin Qiu
Partner
|
|||
Jianming Yu
Founder, Managing Partner
|
|||
Jianming Yu
Founder, Managing Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Benjamin Qiu invest in?
Benjamin Qiu invests primarily in Health Care, Pharmaceutical and Biotechnology startups, most often at Series A and Series B stage. Most of the 6 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Benjamin Qiu?
Public channels for Benjamin Qiu include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Benjamin Qiu last invest?
The most recent investment recorded for Benjamin Qiu closed in Dec 2021. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
